Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9322549 | Fertility and Sterility | 2005 | 8 Pages |
Abstract
The concentrations of FF-MAS in a novel 0.2% recombinant human albumin-based formulation of FF-MAS did not increase the risk of chromosomal abnormalities in pre-embryos or blastomeres. No statistically significant differences in fertilization rate, cleavage rate, or number of good quality pre-embryos were found among the four groups.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Anne M.D., Søren M.Sc., Karin M.Sc., Per Emil M.D., Inge M.Sc., Benedicte M.D., Mona M.Sc., Leif M.D., Christian D.V.M., Karsten M.Sc.,